Musculoskeletal manifestations in a Portuguese cohort of 235 inflammatory bowel disease patients

被引:0
|
作者
Fernandes, B. M. [1 ]
Rosa-Goncalves, D. [2 ]
Magro, F. [3 ]
Costa, L. [1 ]
Bernardes, M. [1 ]
机构
[1] Ctr Hosp Univ Sao Joao, Serv Reumatol, Porto, Portugal
[2] Ctr Hosp Entre Douro & Vouga, Serv Reumatol, Santa Maria Feira, Portugal
[3] Ctr Hosp Univ Sao Joao, Serv Gastroenterol, Porto, Portugal
来源
ARP RHEUMATOLOGY | 2022年 / 1卷 / 02期
关键词
Inflammatory bowel disease; Rheumatic manifestations; SOCIETY CLASSIFICATION CRITERIA; PERIPHERAL SPONDYLOARTHRITIS; PREVALENCE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Musculoskeletal symptoms represent the most common extraintestinal manifestations of inflammatory bowel disease (IBD) and a major cause of impaired quality of life in these patients. Spondyloarthritis (SpA) is classically associated with IBD, but other rheumatic manifestations may occur. Objective: To characterize musculoskeletal symptoms and rheumatic diseases in an IBD cohort. Methods: Retrospective monocentric descriptive study including all the patients with IBD consecutively referred from Gastroenterology to the Reumatology Department (from January of 2013 to April of 2021) in a Portuguese tertiary university hospital. Demographic and clinical data were collected and musculoskeletal symptoms and rheumatic diseases diagnosed in the Rheumatology outpatient center were registered. Results: A total of 235 patients were included: 177 (75.3%) with Crohn ' s disease (CD) and 58 (24.7%) with ulcerative colitis. Musculoskeletal symptoms were observed in 142 (60.4%) patients and 105 (44.7%) had some rheumatic condition. Regarding spondyloarthritis, 46 (19.6%) patients fulfilled ASAS (Assessment of SpondyloArthritis international Society) criteria for axial SpA and 5 (2.1%) for peripheral SpA. Osteoarthritis (n=70, 29.8%) and osteoporosis (n=33, 14%) were the most frequent non-inflammatory rheumatic conditions observed, mostly previously undiagnosed. No significant differences were observed between CD and UC. Conclusion: Rheumatic conditions are frequent in IBD patients and are not limited to SpA features. They remain mostly undiagnosed and the collaboration between gastroenterologists and rheumatologists is important for their best management.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [1] MUSCULOSKELETAL MANIFESTATIONS IN A COHORT OF 234 INFLAMMATORY BOWEL DISEASE PATIENTS
    Fernandes, B. M.
    Bernardes, M.
    Goncalves, D. R.
    Magro, F.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 919 - 920
  • [2] Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients
    Salvarani, C
    Vlachonikolis, IG
    van der Heijde, DM
    Fornaciari, G
    Maechioni, P
    Beltrami, M
    Olivieri, I
    Di Gennaro, F
    Politi, P
    Stockbrügger, RW
    Russel, MG
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (12) : 1307 - 1313
  • [3] Phenotype of Musculoskeletal Manifestations in a Canadian Inception Cohort of Pediatric Patients with Inflammatory Bowel Disease
    Dzongowski, Emily
    Miller, Michael
    Schmidt, Melanie
    Suthar, Nidhi Rashmikant
    Walters, Thomas D.
    Griffiths, Anne
    El-Matary, Wael
    Benchimol, Eric
    deBruyn, Jennifer
    Berard, Roberta A.
    Crowley, Eileen
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4044 - 4045
  • [4] Phenotype of Musculoskeletal Manifestations in a Canadian Inception Cohort of Pediatric Patients With Inflammatory Bowel Disease
    Dzongowski, Emily
    Miller, Michael
    Schmidt, Melanie
    Walters, Thomas
    Griffiths, Anne
    El-Matary, Wael
    Benchimol, Eric
    deBruyn, Jennifer
    Berard, Roberta
    Crowley, Eileen
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 41 - 41
  • [5] Musculoskeletal Manifestations of Inflammatory Bowel Disease
    Bourikas, Leonidas A.
    Papadakis, Konstantinos A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : 1915 - 1924
  • [6] MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Rodriguez-Merlos, P.
    Ruiz-Ramirez, M. A.
    Plasencia, C.
    Navarro-Compan, V.
    Suarez-Ferrer, C.
    Martin-Arranz, E.
    Martin Arranz, M. D.
    Peiteado, D.
    Bonilla, G.
    Sanchez Azofra, M.
    Poza Cordon, J.
    Franco Gomez, K. N.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 731 - 732
  • [7] Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease
    Sheth, Tejas
    Pitchumoni, C. S.
    Das, Kiron M.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [8] MUSCULOSKELETAL MANIFESTATIONS ON TNF-TARGETED THERAPIES IN INFLAMMATORY BOWEL DISEASE COHORT
    Subramaniam, K.
    Tymms, K.
    Pavli, P.
    Shadbolt, B.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 19 - 19
  • [9] Musculoskeletal manifestations on TNF-targeted therapies in inflammatory bowel disease cohort
    Subramaniam, K.
    Perera, C.
    Tymms, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 62 - 63
  • [10] Musculoskeletal Manifestations on TNF-Targeted Therapies in Inflammatory Bowel Disease Cohort
    Subramaniam, Kavitha
    Tymms, Kathie
    Shadbolt, Bruce
    Pavli, Paul
    GASTROENTEROLOGY, 2012, 142 (05) : S782 - S782